Graham Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$298K Buy
56,373
+30,764
+120% +$197K 0.01% 899
2026
Q1
$186K Sell
25,609
-3,346
-12% -$30.3K ﹤0.01% 965
2025
Q4
$279K Buy
28,955
+2,077
+8% +$21.5K 0.01% 891
2025
Q3
$328K Sell
26,878
-44,447
-62% -$467K 0.01% 820
2025
Q2
$570K Sell
71,325
-45,778
-39% -$321K 0.01% 767
2025
Q1
$850K Buy
117,103
+13,160
+13% +$95.7K 0.01% 607
2024
Q4
$716K Buy
103,943
+91,009
+704% +$626K 0.01% 598
2024
Q3
$95.3K Buy
+12,934
New +$121K ﹤0.01% 1004
2024
Q1
Sell
-17,779
Closed -$345K 1229
2023
Q4
$345K Buy
+17,779
New +$328K 0.01% 690

Other funds holding NUS

Graham Capital Management's NUS Position: Q2 2026 in Review

Graham Capital Management increased its Nu Skin (NUS) stake by 120% in Q2 2026, buying an estimated $197K and bringing the position to 56,373 shares worth $298K. The position accounts for 0.01% of the portfolio, ranked #899.

Graham Capital Management first reported a position in NUS in Q4 2023 and has held it in 9 quarters since. The position peaked at $850K in Q1 2025. 162 funds tracked by Wall St. Rank hold NUS as of Q2 2026.

  • Graham Capital Management held 56,373 shares of Nu Skin worth $298K as of Q2 2026.
  • Graham Capital Management bought 30,764 Nu Skin shares in Q2 2026, an estimated $197K.
  • Nu Skin made up 0.01% of Graham Capital Management's portfolio in Q2 2026, its #899 holding.
  • Graham Capital Management first reported a position in Nu Skin in Q4 2023 and has held it in 9 quarters since.
  • Graham Capital Management's Nu Skin position peaked at $850K in Q1 2025.
  • 162 funds tracked by Wall St. Rank held Nu Skin as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.